Biomedical Bonding (BMB) has secured SEK 3 million (~USD $0.3 million) in funding to fast-track the development of their composite-based universal bone fixators for fracture treatment.
“BMB’s quest is to become the first MedTech company to provide implants that adapt to fractures in real-time during surgery, as opposed to pre-manufactured metal plates,” said Michael Malkoch, CEO and Founder of BMB.
In 2021, BMB received a patent in China for a novel primer formulation. The product is an enabling technology and part of the Bonevolent™ platform developed to advance strong adhesion to metal implants, for use in resin-based fixation of bone fractures and dental restoration.
Biomedical Bonding (BMB) has secured SEK 3 million (~USD $0.3 million) in funding to fast-track the development of their composite-based universal bone fixators for fracture treatment.
"BMB’s quest is to become the first MedTech company to provide implants that adapt to fractures in real-time during surgery, as opposed to pre-manufactured metal...
Biomedical Bonding (BMB) has secured SEK 3 million (~USD $0.3 million) in funding to fast-track the development of their composite-based universal bone fixators for fracture treatment.
“BMB’s quest is to become the first MedTech company to provide implants that adapt to fractures in real-time during surgery, as opposed to pre-manufactured metal plates,” said Michael Malkoch, CEO and Founder of BMB.
In 2021, BMB received a patent in China for a novel primer formulation. The product is an enabling technology and part of the Bonevolent™ platform developed to advance strong adhesion to metal implants, for use in resin-based fixation of bone fractures and dental restoration.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
